Business · 1 sources covering this

India's pharma, healthcare deal volumes rise 23% in Q3 2026: Report

India's pharma and healthcare sector recorded 87 deals worth $4.3 billion in Q3 2026, as private equity activity surged and public market fundraising gained momentum.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
India's pharma, healthcare deal volumes rise 23% in Q3 2026: Report
India's pharma and healthcare sector recorded 87 deals worth $4.3 billion in Q3 2026, as private equity activity surged and public market fundraising gained momentum.
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/75544894ed2b88b50558ba33f12d3ef534634e82"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="India's pharma, healthcare deal volumes rise 23% in Q3 2026: Report"></iframe>

India's pharma, healthcare deal volumes rise 23% in Q3 2026: Report

How 1 sources are covering this

India's pharma, healthcare deal volumes rise 23% in Q3 2026: Report

More from Business

US economy expands 3.4% in Q3 as consumer spending, AI investment rise

Al Nassr Vs Al Kholood Live Streaming: Likely Lineups; Where To Watch Saudi Pro League Match Online?

Alphabet Shares Extend Decline To 13.7%, Biggest Drop On Record

Jailer 2 Box Office Collection Day 15: Rajinikanth Starrer Enters Third Week, Edges Closer To Next Milestone

Reader

Trust & legal

Across the network